The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 02, 2012

Filed:

Dec. 12, 2007
Applicants:

Mike Rainone, Palestine, TX (US);

Erica M. Phillips, Woodstock, GA (US);

Richard Hantke, Chicago, IL (US);

Shawn R. Feaster, Duluth, GA (US);

Daniel Baird, Woodstock, GA (US);

Thomas Edward Plowman, Cary, NC (US);

Talbot Presley, Palestine, TX (US);

Inventors:

Mike Rainone, Palestine, TX (US);

Erica M. Phillips, Woodstock, GA (US);

Richard Hantke, Chicago, IL (US);

Shawn R. Feaster, Duluth, GA (US);

Daniel Baird, Woodstock, GA (US);

Thomas Edward Plowman, Cary, NC (US);

Talbot Presley, Palestine, TX (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/1455 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are methods and devices for continuous in vivo monitoring of a potential bacterial infection site. Disclosed devices may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of a hospital acquired infection, thereby providing for earlier intervention. Disclosed methods utilize optical fibers to deliver an excitation signal to an area in which pathogenic bacteria may exist. In the presence of the excitation signal, bacterial pathogens may autofluoresce with a unique spectral signature. Upon generation of a fluorescent emission, an optically detectable emission signal may be transmitted to a detection/analysis device. Analysis of the characteristics of the emission signal produced in response to the excitation signal may be used to determine the presence or concentration of pathogens at the site of inquiry, following which real time information may be transmitted to medical personnel via a wireless transmission system.


Find Patent Forward Citations

Loading…